Fig. 2From: Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysisBreast cancer-specific survival for patients with IBC and T4-non-IBC stratified by breast cancer moleculor subtype. a HR+/HER2-;(b)HR+/HER2+;(c)HR−/HER2+;(d)HR−/HER2-. HER2 indicates human epidermal growth factor receptor 2; HR, hormone receptor; IBC,Inflammatory breast cancer; T4-non-IBC, T4 noninflammatory breast cancerBack to article page